These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19022170)

  • 21. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of patients discharged from pharmacy-managed cardiovascular disease management.
    Olson KL; Delate T; Rasmussen J; Humphries TL; Merenich JA;
    Am J Manag Care; 2009 Aug; 15(8):497-503. PubMed ID: 19670953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cilostazol (Pletal) in the management of intermittent claudication.
    Bradbury AW
    Int J Clin Pract; 2003 Jun; 57(5):405-9. PubMed ID: 12846346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipids and CVD management: towards a global consensus.
    Ballantyne C; Arroll B; Shepherd J
    Eur Heart J; 2005 Nov; 26(21):2224-31. PubMed ID: 15972289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nurse-led cardiac rehabilitation programme improves health behaviours and cardiac physiological risk parameters: evidence from Chengdu, China.
    Jiang X; Sit JW; Wong TK
    J Clin Nurs; 2007 Oct; 16(10):1886-97. PubMed ID: 17880478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Lowering of Vascular Atherosclerotic Risk (LOVAR) program: an approach to modifying cerebral, cardiac, and peripheral vascular disease.
    Castaldo JE; Reed JF
    J Stroke Cerebrovasc Dis; 2008; 17(1):9-15. PubMed ID: 18190815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical treatment of peripheral arterial disease and claudication.
    Hiatt WR
    N Engl J Med; 2001 May; 344(21):1608-21. PubMed ID: 11372014
    [No Abstract]   [Full Text] [Related]  

  • 33. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract]   [Full Text] [Related]  

  • 34. Nurse-led clinics reduce severity of childhood atopic eczema: a review of the literature.
    Moore E; Williams A; Manias E; Varigos G
    Br J Dermatol; 2006 Dec; 155(6):1242-8. PubMed ID: 17107396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological and functional impact of an unsupervised but supported exercise programme for claudicants.
    Roberts AJ; Roberts EB; Sykes K; De Cossart L; Edwards P; Cotterrell D
    Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):319-24. PubMed ID: 18547828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral arterial disease.
    Hiatt WR; Nehler MR
    Adv Intern Med; 2001; 47():89-110. PubMed ID: 11795081
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
    Rehring TF; Stolcpart RS; Hollis HW;
    J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computerized community cholesterol control (4C): meeting the challenge of secondary prevention.
    Gilutz H; Novack L; Shvartzman P; Zelingher J; Bonneh DY; Henkin Y; Maislos M; Peleg R; Liss Z; Rabinowitz G; Vardy D; Zahger D; Ilia R; Leibermann N; Porath A
    Isr Med Assoc J; 2009 Jan; 11(1):23-9. PubMed ID: 19344008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.